Lymphocyte-Rich Classical Hodgkin Lymphoma: A Case with Difficulty in Distinguishing from Nodular Lymphocyte-Predominant Hodgkin Lymphoma

被引:1
|
作者
Sakai, Jun [1 ]
Tanae, Ken [2 ]
Takahashi, Naoki [1 ]
Nagata, Koji [3 ]
Yoshino, Tadashi [4 ]
Tamaru, Jun-ichi [5 ]
Niitsu, Nozomi [1 ]
机构
[1] Saitama Med Univ, Int Med Ctr, Dept Hematol, 1397-1 Yamane, Saitama 3501298, Japan
[2] Iwate Cent Hosp, Dept Hematol, Morioka, Iwate, Japan
[3] Saitama Med Univ, Int Med Ctr, Dept Pathol, Saitama, Japan
[4] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama, Japan
[5] Saitama Med Univ, Med Ctr, Dept Pathol, Saitama, Japan
关键词
lymphocyte-rich classical Hodgkin lymphoma; nodular lymphocyte-predominant Hodgkin lymphoma; ABVD;
D O I
10.3960/jslrt.55.23
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 35-year-old man was referred to our hospital because of left supraclavicular and cervical lymphadenopathies. Histopathological examination of the lymph nodes revealed reactive lymphadenopathy. He visited our hospital three years after the initial diagnosis because of enlarged left cervical lymph nodes. Histopathologically, both Hodgkin/Reed-Sternberg (H/ RS) and lymphocyte-predominant (LP) cells were found in the lymph node. We first suspected nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), because these cells were CD15 -and CD30(-). However, the diagnosis of lymphocyte-rich classical Hodgkin lymphoma (LRCHL) was finally confirmed, because these cells were found to be CD20(-), Bob. 1(+), Oct. 2(-), and BCL6(-) by additional immunostaining. The patient was treated with six cycles of ABVD chemotherapy, and a complete response was achieved. However, he underwent autologous stem-cell transplantation after high-dose chemotherapy owing to a relapse 10 months after primary treatment. Distingushing LRCHL from NLPHL was difficult in this patient, because histopathological examination showed both H/ RS and LP cells, and immunostaining revealed these cells to be triple negative (CD15(-), CD30 -and CD20(-)). Accumulation of such cases are necessary to establish better criteria for the differential diagnosis and assessment of clinical behavior.
引用
收藏
页码:23 / 28
页数:6
相关论文
共 50 条
  • [1] Utility of Fascin and JunB in Distinguishing Nodular Lymphocyte Predominant From Classical Lymphocyte-rich Hodgkin Lymphoma
    Bhargava, Parul
    Pantanowitz, Liron
    Pinkus, Geraldine S.
    Pinkus, Jack L.
    Paessler, Michele E.
    Roullet, Michele
    Gautam, Shiva
    Bagg, Adam
    Kadin, Marshall E.
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2010, 18 (01) : 16 - 23
  • [2] Nodular lymphocyte-predominant Hodgkin lymphoma
    Tsai, Henry K.
    Mauch, Peter M.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2007, 17 (03) : 184 - 189
  • [3] Utility of fascin and Jun-B in differentiating nodular lymphocyte-predominant from classical lymphocyte-rich Hodgkin lymphoma
    Bhargava, P
    Pantanowitz, L
    Pinkus, JL
    Pinkus, GS
    Bagg, A
    Paessler, ME
    Kadin, ME
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 124 (04) : 643 - 643
  • [4] Nodular lymphocyte-predominant Hodgkin lymphoma
    Fuchs M.
    Eichenauer D.A.
    Nogová L.
    Diehl V.
    Engert A.
    [J]. Current Hematologic Malignancy Reports, 2008, 3 (3) : 126 - 131
  • [5] Nodular lymphocyte-predominant Hodgkin lymphoma
    Subhawong, Andrea P.
    Ali, Syed Z.
    Tatsas, Armanda D.
    [J]. CANCER CYTOPATHOLOGY, 2012, 120 (04) : 254 - 260
  • [6] Nodular lymphocyte-predominant Hodgkin lymphoma
    Savage, Kerry J.
    Mottok, Anja
    Fanale, Michelle
    [J]. SEMINARS IN HEMATOLOGY, 2016, 53 (03) : 190 - 202
  • [7] Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    Eichenauer, Dennis A.
    [J]. TURKISH JOURNAL OF HEMATOLOGY, 2019, 36 : 19 - 20
  • [8] Update on Nodular lymphocyte-Predominant Hodgkin lymphoma
    Eichenauer, Dennis
    [J]. TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 : 25 - 26
  • [9] Management of nodular lymphocyte-predominant Hodgkin lymphoma
    Eichenauer, Dennis A.
    Engert, Andreas
    [J]. HEMATOLOGICAL ONCOLOGY, 2013, 31 : 47 - 50
  • [10] Nodular lymphocyte-predominant Hodgkin's lymphoma
    Nogovà L.
    Diehl V.
    Engert A.
    [J]. Current Hematologic Malignancy Reports, 2006, 1 (1) : 60 - 65